82.78USD-1.59%Mkt Cap: 1.88B $P/E: 21.171d ago
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel …
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Avg
1M Perf
Avg
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap1.88B $
Enterprise Value2.06B $
Revenue (TTM)923.71M $
Gross Profit542.06M $
Net Income (TTM)78.34M $
Revenue/Share45.33 USD
Last Price82.78 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees970
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00182C1036
Valuation
P/E (Trailing)21.17
P/E (Forward)7.74
PEG—
EV/EBITDA10.43
EV/Revenue2.23
P/S2.04
P/B3.14
EPS (TTM)3.91
EPS (Forward)10.69
52W Range
62.6155% of range99.50
52W High99.50 USD
52W Low62.61 USD
Profitability
Gross Margin61.36%
Oper. Margin16.30%
EBITDA Margin21.37%
Profit Margin8.87%
ROE14.49%
ROA5.44%
Growth
Revenue Growth20.50%
Earnings Growth86.10%
Cash Flow & Leverage
Operating CF185.22M $
CapEx (TTM)34.32M $
FCF Margin15.18%
FCF Yield7.45%
Net Debt304.15M $
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity1.14
Current Ratio3.12
Quick Ratio2.43
Book Value/Sh26.34 USD
Cash/Share15.38 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJul 18, 2013
Analyst Consensus
Rating—
Target (Mean)112.71 USD
Upside (mean)+36.2%
Target Range100.00 USD – 124.00 USD
$100.00+36.2% to mean$124.00
# Analysts7
Ownership
Shares Out.22.73M
Float19.41M
Insiders5.56%
Institutions110.35%
Short Interest
Short Ratio10.1d
Short % Float17.19%
Short % Out.14.08%
Shares Short3.20M
Short (prev mo.)3.62M
Technical
SMA 5080.71 (+2.6%)
SMA 20082.66 (+0.1%)
Beta0.44
S&P 52W Chg20.05%
Avg Vol (30d)286.86K
Avg Vol (10d)375.67K
Technical Indicators
RSI (14)54.4
MACD0.8965
MACD Signal0.6550
MACD Hist.+0.2415
BB Upper86.08 USD
BB Middle81.19 USD
BB Lower76.31 USD
BB Width12.03%
ATR (14)2.443 USD
Vol Ratio (20d)0.78x